2 Amendments of Frédérique RIES related to 2011/0402(CNS)
Amendment 622 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.6 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.6 – paragraph 1
An improved understanding of health, disease and disease processes at all ages is needed to develop new and more effective diagnostics. Innovative and existing technologies will be developed with the goal of significantly improving disease outcomes through earlier, more accurate diagnosis and by allowing for more patient-adapted treatment. Mutations causing genetic diseases will be identified and the availability of diagnostic tests will be significantly increased.
Amendment 636 #
Proposal for a decision
Annex 1 – section 3 – point 1 – point 1.9 – paragraph 1
Annex 1 – section 3 – point 1 – point 1.9 – paragraph 1
Clinical trials are the means to transfer biomedical knowledge to application in patients and support for these will be provided, as well as for the improvement of their practice. Examples include the development of better methodologies to allow trials to focus on relevant population groups, including those suffering from rare diseases, other concomitant diseases and/or already undergoing treatment, the determination of comparative effectiveness of interventions and solutions, as well as enhancing the use of databases and electronic health records as data sources for trials and knowledge transfer. Specific support should be ensured for the preclinical and/or clinical development of substances with a clear potential to address largely unmet medical needs, such as designated orphan drugs. Similarly, support for the transfer of other types of interventions such as those related to independent living into real world environments will be provided.